Water-soluble combinations of dexanabinol: Prodrugs and analogs

Pharmazie

Volumn 55, Issue 3, 2000, Pages 167-171

  Pop, E ^a,b  

^a Alchem Laboratories Corporation   (United States)

^b ALCHKM Laboratories Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOL DERIVATIVE; DEXANABINOL; PRODRUG;

ACYLATION; DRUG DESIGN; DRUG HYDROLYSIS; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; DRUG SYNTHESIS; REVIEW;

ANIMALS; DRUG STABILITY; HUMANS; HYDROLYSIS; NEUROPROTECTIVE AGENTS; PRODRUGS; SOLUBILITY; TETRAHYDROCANNABINOL;

EID: 0034072816     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Mechoulam, R.; Lander, N.; Breuer, A.; Zahalka, J.: Tetrahedron: Asymmetry 315, 1 (1990)
2. Feigenbaum, J. J.; Bergmann, F.; Richmond, S. A.; Mechoulam, R.; Nadler, V.; Kloog, Y.; Sokolowsky, M.: Proc. Natl. Acad. Sci. U.S.A. 86, 9584 (1989)
3. Eshhar, N.; Striem, S.; Kohen, R.; Tirosh, O.; Biegon, A.: Eur. J. Pharmacol. 283, 1 (1955)
4. Gallily, R.; Yamin, A.; Waksmann, Y.; Ovadia, H.; Weidenfeld, J.; Bar-Joseph, A.; Biegon, A.; Mechoulam, R.: Eur. J. Pharmacol., Exp. 283, 2918 (1997)
5. Shohami, E.; Novikov, M.; Mechoulam, R.: J. Neurotrauma 109, 10 (1993)
6. Yoles, E.; Belkin, M.; Schwartz, M.: J. Neurotrauma 13, 49 (1995)
7. Bar-Joseph, A.; Berkovitch, Y.; Adamchik, J.; Biegon, A.: Mol. Chem. Neuropathol. 23, 125 (1994)
8. Brewster, M. E.; Pop, E.; Foltz, R.; Griffith, W.; Amselem, S.; Biegon, A.: J. Clin. Pharmacol. Ther. 35, 361 (1997)
9. Pop, E.; Brewster, M. E.; Liu, Z. Z.; Soti, F.; Rachwal, S.; Dinculescu, A.; Nadler, V.; Barenholz, Y.; Mechoulam, R.; Biegon, A.: Proceeding of the 1-St World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. APGI/APV: p. 127 Budapest, 1995
10. Pop, E.; Liu, Z. Z.; Brewster, M. E.; Barenholz, Y.; Korablyov, V.; Mechoulam, R.; Nadler, V.; Biegon, A.: Pharm. Res. 13, 62 (1996)
11. Pop, E.; Rachwal, S.; Vlasak, J.; Biegon, A.; Zharikova, A.; Prokai, L.: J. Pharm. Sci. 88, 1156 (1999)
12. Pop, E.; Rachwal, S.; Vlasak, J.; Brewster, M. E.; Prokai, L.; Biegon, A.: Proceeding of the 2-Nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. APGI/APV; p. 101 Paris, 1998
13. Pop, E.; Soti, F.; Brewster, M. E.; Barenholz, Y.; Korablyov, V.; Mechoulam, R.; Nadler, V.; Biegon, A.: Pharm. Res. 13, 469 (1996)
14. Pop, E.; Soti, F.; Biegon, A.; Brewster, M. E.: Org. Prep. Proc. Int. Briefs 29, 341 (1997)
15. Pop, E.; Rachwal, S.: Org. Prep. Proc Int. Briefs, 31, 565 (1999)
16. Pop, E.; Soti, F.; Brewster, M. E.: Synth. Commun. 25, 4099 (1995)
17. Bundgaard, H. in Bundgaard, H. (Ed.) Design of Prodrugs; p. 1, Elsevier, New York 1985
18. Nadler, V.; Mechoulam, R.; Sokolovsky, M.: Brain Res. 622, 79 (1993)
19. Eshhar, N.; Striem, S.; Biegon, A.: Neuroreport 5, 237 (1993)
20. Nadler, V,; Mechoulam, R.; Sokolovsky, M.: Neurosci. Lett. 43, 162 (1993)
21. Munson, P. J.; Rodbard, D.: Anal. Biochem. 107, 220 (1980)